dipyridamole has been researched along with enalapril in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abete, P; Acanfora, D; Ferrara, N; Furgi, G; Guerra, N; Leosco, D; Longobardi, G; Nicolino, A; Papa, A; Rengo, F | 1 |
| Motz, W; Strauer, BE | 1 |
| Frohlich, ED; Hosoya, K; Nunez, E; Susic, D | 1 |
| Gallopin, M; Giorgetti, A; L'Abbate, A; Marabotti, C; Neglia, D; Palombo, C; Parodi, O; Sambuceti, G; Simonetti, I | 1 |
| Boonyen, M; Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakul, P; Tosukhowong, P | 1 |
1 review(s) available for dipyridamole and enalapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for dipyridamole and enalapril
| Article | Year |
|---|---|
Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Captopril; Cross-Over Studies; Dipyridamole; Double-Blind Method; Echocardiography; Enalapril; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Failure | 1995 |
Improvement of coronary flow reserve after long-term therapy with enalapril.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Enalapril; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardium; Organ Size; Pulmonary Artery; Time Factors; Vasodilator Agents | 1996 |
Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Coronary Circulation; Dipyridamole; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Single-Blind Method; Tomography, Emission-Computed; Vasodilator Agents; Verapamil | 1997 |
5 other study(ies) available for dipyridamole and enalapril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Dipyridamole; Enalapril; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasodilator Agents | 1997 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Enalapril; Endothelial Cells; Glutathione; Humans; Kidney Function Tests; Kidney Glomerulus; Malondialdehyde; Nephrosis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Platelet Aggregation Inhibitors; Proteinuria; Reishi; Renal Circulation; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |